ATE501153T1 - Kristallisation von festen formen von clopidogreladditionssalzen - Google Patents
Kristallisation von festen formen von clopidogreladditionssalzenInfo
- Publication number
- ATE501153T1 ATE501153T1 AT04763994T AT04763994T ATE501153T1 AT E501153 T1 ATE501153 T1 AT E501153T1 AT 04763994 T AT04763994 T AT 04763994T AT 04763994 T AT04763994 T AT 04763994T AT E501153 T1 ATE501153 T1 AT E501153T1
- Authority
- AT
- Austria
- Prior art keywords
- clopidogreladdion
- crystallization
- salts
- solid forms
- clopidogrel
- Prior art date
Links
- 238000002425 crystallisation Methods 0.000 title 1
- 230000008025 crystallization Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 abstract 2
- 229960003009 clopidogrel Drugs 0.000 abstract 2
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 abstract 2
- 229950010477 clopidogrel hydrogen sulphate Drugs 0.000 abstract 2
- FDEODCTUSIWGLK-UHFFFAOYSA-N hydrogen sulfate;hydron;methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate Chemical compound OS(O)(=O)=O.C1CC=2SC=CC=2CN1C(C(=O)OC)C1=CC=CC=C1Cl FDEODCTUSIWGLK-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 abstract 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 abstract 1
- IVNFTPCOZIGNAE-UHFFFAOYSA-N propan-2-yl hydrogen sulfate Chemical compound CC(C)OS(O)(=O)=O IVNFTPCOZIGNAE-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compounds Of Unknown Constitution (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Glass Compositions (AREA)
- Liquid Crystal Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10337773A DE10337773A1 (de) | 2003-08-13 | 2003-08-13 | Kristallisation von festen Formen von Clopidogrel-Additionssalzen |
| PCT/EP2004/008989 WO2005016931A2 (en) | 2003-08-13 | 2004-08-11 | Crystallisation of solid forms of clopidogrel addition salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501153T1 true ATE501153T1 (de) | 2011-03-15 |
Family
ID=34177655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04763994T ATE501153T1 (de) | 2003-08-13 | 2004-08-11 | Kristallisation von festen formen von clopidogreladditionssalzen |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1656381B1 (de) |
| AT (1) | ATE501153T1 (de) |
| DE (2) | DE10337773A1 (de) |
| ES (1) | ES2362660T3 (de) |
| HR (1) | HRP20110418T1 (de) |
| PL (1) | PL1656381T3 (de) |
| PT (1) | PT1656381E (de) |
| SI (1) | SI1656381T1 (de) |
| WO (1) | WO2005016931A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1740593T3 (pl) * | 2004-04-19 | 2016-09-30 | Sposoby wytwarzania wodorosiarczanu klopidogrelu w formie polimorficznej I | |
| EP1693375A1 (de) * | 2005-02-21 | 2006-08-23 | KRKA, tovarna zdravil, d.d., Novo mesto | Verfahren zur Herstellung von Clopidrogel hydrogen sulfat in Form I |
| KR20080055860A (ko) * | 2006-08-03 | 2008-06-19 | 테바 파마슈티컬 인더스트리즈 리미티드 | 클로피도그렐 바이설페이트의 제조 방법 |
| SI22383A (sl) * | 2006-09-22 | 2008-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli |
| KR101378596B1 (ko) | 2006-12-27 | 2014-03-26 | 경동제약 주식회사 | 결정성 클로피도그렐 · 황산염 형태 ｉ의 제조방법 |
| PL382055A1 (pl) * | 2007-03-23 | 2008-09-29 | Koźluk Tomasz Nobilus Ent | Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu |
| EP2107061A1 (de) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Herstellungsverfahren für optisch angereichertes Clopidogrel |
| CN102083837B (zh) * | 2008-06-24 | 2013-09-18 | Zach系统股份公司 | 硫酸氢氯吡格雷晶型i的制备方法 |
| WO2011010318A1 (en) * | 2009-07-23 | 2011-01-27 | Praveen Laboratories Private Limited | Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals |
| WO2011042804A2 (en) | 2009-10-08 | 2011-04-14 | Jubliant Life Sciences Limited | An improved process for the preparation of clopidogrel hydrogen sulfate form i |
| CN102358743A (zh) * | 2011-11-05 | 2012-02-22 | 江南大学 | 一种制备无定形氯吡格雷硫酸氢盐的简便方法 |
| CN102432625A (zh) * | 2011-11-05 | 2012-05-02 | 江南大学 | 一种制备高纯度i型氯吡格雷硫酸氢盐的结晶方法 |
| CN103044444B (zh) * | 2013-01-21 | 2015-04-15 | 上海现代哈森（商丘）药业有限公司 | 一种高纯度ⅰ型(+)-(s)-硫酸氢氯吡格雷的合成方法 |
| CN103923100B (zh) * | 2014-04-03 | 2019-05-14 | 浙江华海药业股份有限公司 | 一种硫酸氢氯吡格雷的精制方法 |
| CN104478895B (zh) * | 2014-12-05 | 2017-04-12 | 广东东阳光药业有限公司 | 氯吡格雷硫酸盐的制备方法 |
| CN107118221B (zh) * | 2017-05-24 | 2021-09-07 | 常州制药厂有限公司 | 一种硫酸氢氯吡格雷晶型i制备方法 |
| CN107163060B (zh) * | 2017-05-24 | 2021-03-02 | 常州制药厂有限公司 | 一种硫酸氢氯吡格雷晶型ii制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2530247B1 (fr) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
| FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
| FR2779726B1 (fr) * | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
| EP1425681A4 (de) * | 2001-07-02 | 2004-10-20 | Thomas W Wilson | Verfahren und system zur analyse der betriebsmittelzuteilung |
| JP2005514387A (ja) * | 2001-12-18 | 2005-05-19 | テバ ファーマシューティカル インダストリーズ リミティド | クロピドグレル硫酸水素塩の多型体 |
| CZ297472B6 (cs) * | 2002-08-27 | 2006-12-13 | Zentiva, A.S. | Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I |
| AU2003285841A1 (en) * | 2002-11-28 | 2004-06-18 | Anpharm Przedsiebiorstwo Farmaceutyczne S.A. | A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate |
| AU2003238664A1 (en) * | 2003-03-12 | 2004-09-30 | Cadila Healthcare Limited | Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate |
-
2003
- 2003-08-13 DE DE10337773A patent/DE10337773A1/de not_active Withdrawn
-
2004
- 2004-08-11 PT PT04763994T patent/PT1656381E/pt unknown
- 2004-08-11 ES ES04763994T patent/ES2362660T3/es not_active Expired - Lifetime
- 2004-08-11 HR HR20110418T patent/HRP20110418T1/hr unknown
- 2004-08-11 AT AT04763994T patent/ATE501153T1/de not_active IP Right Cessation
- 2004-08-11 SI SI200431684T patent/SI1656381T1/sl unknown
- 2004-08-11 EP EP04763994A patent/EP1656381B1/de not_active Expired - Lifetime
- 2004-08-11 WO PCT/EP2004/008989 patent/WO2005016931A2/en not_active Ceased
- 2004-08-11 DE DE602004031744T patent/DE602004031744D1/de not_active Expired - Lifetime
- 2004-08-11 PL PL04763994T patent/PL1656381T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10337773A1 (de) | 2005-03-24 |
| WO2005016931A3 (en) | 2005-04-28 |
| DE602004031744D1 (de) | 2011-04-21 |
| HRP20110418T1 (hr) | 2011-06-30 |
| PL1656381T3 (pl) | 2011-08-31 |
| ES2362660T3 (es) | 2011-07-11 |
| EP1656381A2 (de) | 2006-05-17 |
| EP1656381B1 (de) | 2011-03-09 |
| PT1656381E (pt) | 2011-06-16 |
| WO2005016931A2 (en) | 2005-02-24 |
| SI1656381T1 (sl) | 2011-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE501153T1 (de) | Kristallisation von festen formen von clopidogreladditionssalzen | |
| DE602004013405D1 (de) | Polymorphe formen von valsartan | |
| DE60230327D1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
| CY1114303T1 (el) | Νεο οξινο θειικο αλας | |
| PL1881967T3 (pl) | Podstawione benzo[d]izoksazol-3-iloaminy jako środki przeciwbólowe | |
| ATE489365T1 (de) | Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon | |
| TW200640859A (en) | Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists | |
| CY1117841T1 (el) | Διεργασια για την παρασκευη υδροχλωρικης οξυκωδονης εχουσας λιγοτερο απο 25 ppm 14-yδροξυκωδεϊνονη | |
| TW200718420A (en) | Formulation of a thienopyridine platelet aggregation inhibitor | |
| IL185576A0 (en) | Crystallisation and purification of glycopyrronium bromide | |
| CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
| CY1109740T1 (el) | Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ | |
| PL1620425T3 (pl) | Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu | |
| NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
| EA200701687A1 (ru) | Гидрохлорид аморфного лерканидипина | |
| YU101103A (en) | Technical synthesis method for producing tropenol | |
| EA200700146A1 (ru) | Кристаллизированный полиэтилентерефталат, содержащий кремний, и способ его получения | |
| UA106580C2 (uk) | Фармацевтично прийнятні солі тимодепресину і спосіб їх виробництва | |
| MX2007003922A (es) | Nuevas propenonas ciclicas y aciclicas para tratar trastornos del sistema nervioso central. | |
| PL363772A1 (en) | Co-retarding agents for preparing purified brine | |
| BR0214971A (pt) | Processo para a produção de um imunossupressor | |
| ITMI20042231A1 (it) | Cefdinir sale d'ammonio in forma cristallina | |
| UA92752C2 (ru) | Способ получения кристаллического периндоприла | |
| ATE403418T1 (de) | Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid | |
| EA200201100A1 (ru) | Ингибиторы для приготовления очищенного насыщенного солевого раствора |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |